| scholarly article | Q13442814 |
| P50 | author | Anargyros Moulas | Q73457894 |
| Elzbieta Gocek | Q59158098 | ||
| P2093 | author name string | George P Studzinski | |
| P2860 | cites work | The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1 | Q24297359 |
| FES kinases are required for oncogenic FLT3 signaling | Q24297863 | ||
| Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein | Q24297885 | ||
| ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity | Q24299738 | ||
| Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas | Q24306771 | ||
| Rak functions as a tumor suppressor by regulating PTEN protein stability and function | Q24312999 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| The protein kinase complement of the human genome | Q24324497 | ||
| Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases | Q24563242 | ||
| Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications | Q24617091 | ||
| Targeting Src family kinases in anti-cancer therapies: turning promise into triumph | Q27025646 | ||
| Protein tyrosine kinase structure and function | Q28145008 | ||
| Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells | Q28183216 | ||
| Signaling through focal adhesion kinase | Q28198051 | ||
| The hunting of the Src | Q28199081 | ||
| Syk expression and novel function in a wide variety of tissues | Q28202066 | ||
| The Abl family kinases: mechanisms of regulation and signaling | Q28206550 | ||
| A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase | Q28216234 | ||
| FES/FER kinase signaling in hematopoietic cells and leukemias | Q28256217 | ||
| Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product | Q28263712 | ||
| p130Cas is an essential transducer element in ErbB2 transformation | Q28283561 | ||
| Role of ABL family kinases in cancer: from leukaemia to solid tumours | Q28396643 | ||
| Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia | Q28478165 | ||
| Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension | Q28591494 | ||
| Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer | Q29547564 | ||
| The STATs of cancer--new molecular targets come of age | Q29614601 | ||
| Cellular functions regulated by Src family kinases | Q29616038 | ||
| Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma. | Q30009898 | ||
| Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance | Q30010489 | ||
| The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation | Q30155858 | ||
| Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1. | Q30156976 | ||
| Src family kinases: regulation of their activities, levels and identification of new pathways | Q30157744 | ||
| Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli | Q30159764 | ||
| C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases | Q30160101 | ||
| Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia | Q30195143 | ||
| Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells | Q30857023 | ||
| Signal perception and transduction: the role of protein kinases | Q33540927 | ||
| Brk/PTK6 signaling in normal and cancer cell models | Q33690176 | ||
| Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation | Q33888592 | ||
| Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1 | Q34116116 | ||
| Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival | Q34166537 | ||
| The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species | Q34243592 | ||
| Tec kinases: modulators of lymphocyte signaling and development | Q34282327 | ||
| RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK. | Q34420665 | ||
| Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines | Q34441541 | ||
| JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. | Q34595205 | ||
| JAK/STAT signaling in hematological malignancies. | Q34641224 | ||
| Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies | Q34718163 | ||
| Differential transformation capacity of Src family kinases during the initiation of prostate cancer | Q34835580 | ||
| The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling | Q35857092 | ||
| Foot and mouth: podosomes, invadopodia and circular dorsal ruffles | Q35887297 | ||
| The development of imatinib as a therapeutic agent for chronic myeloid leukemia | Q35993288 | ||
| Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia | Q36047171 | ||
| Distinct roles for Syk and ZAP-70 during early thymocyte development | Q36229486 | ||
| Signal transduction of oncogenic Flt3. | Q36251180 | ||
| Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets | Q36532167 | ||
| Establishing the role of tyrosine kinase 2 in cancer | Q36643671 | ||
| TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells | Q36678720 | ||
| Human T and B Lymphocytes Express a Structurally Conserved Focal Adhesion Kinase, pp125FAK | Q36697480 | ||
| Nonreceptor tyrosine kinases in prostate cancer | Q36759212 | ||
| Molecular cloning and expression of chicken C-terminal Src kinase: lack of stable association with c-Src protein | Q36887030 | ||
| Isolation and oncogenic potential of a novel human src-like gene | Q36901119 | ||
| Hematopoietic cytokine receptor signaling | Q36970188 | ||
| Targeting Src in breast cancer | Q37167029 | ||
| Translation of the Philadelphia chromosome into therapy for CML. | Q37344094 | ||
| FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML. | Q37495206 | ||
| TEC family kinases in health and disease--loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK. | Q37868757 | ||
| Evolution of leptin structure and function | Q37890201 | ||
| The JAK-STAT pathway at twenty | Q38004201 | ||
| Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia | Q38011962 | ||
| JAK2 the future: therapeutic strategies for JAK-dependent malignancies | Q38045061 | ||
| Regulation of the SRC family kinases by Csk. | Q38058787 | ||
| Growth hormone and cell growth. | Q38062715 | ||
| SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas | Q39140068 | ||
| In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma | Q39220761 | ||
| BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response | Q39330150 | ||
| Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. | Q39330246 | ||
| Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth | Q39347050 | ||
| The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation | Q39620242 | ||
| Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis | Q39908034 | ||
| The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. | Q40173852 | ||
| Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells | Q40272815 | ||
| Rapid induction and activation of Tec tyrosine kinase in liver regeneration | Q40283302 | ||
| Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. | Q40455282 | ||
| Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. | Q40473904 | ||
| STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications | Q40783216 | ||
| Identification of a novel protein tyrosine kinase that phosphorylates pp60c-src and regulates its activity in neonatal rat brain | Q41813625 | ||
| Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia | Q42794744 | ||
| The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells | Q42827930 | ||
| Cyclin D1 localizes in the cytoplasm of keratinocytes during skin differentiation and regulates cell-matrix adhesion | Q42866996 | ||
| Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. | Q45198729 | ||
| Tony (Anthony James) Pawson, a giant in the field of cell signaling research, dies unexpectedly at the age of 60. | Q45908090 | ||
| Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation | Q46040428 | ||
| Activation of cyclin D1 expression by the ERK5 cascade | Q47670094 | ||
| Signal transduction. Team blue sees red. | Q50759062 | ||
| Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa. | Q53417918 | ||
| Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling | Q57246312 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 125-137 | |
| P577 | publication date | 2014-01-22 | |
| P1433 | published in | Critical Reviews in Clinical Laboratory Sciences | Q5186664 |
| P1476 | title | Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells | |
| P478 | volume | 51 |
| Q49887903 | Advances in studies of tyrosine kinase inhibitors and their acquired resistance |
| Q35745479 | Anchor-based classification and type-C inhibitors for tyrosine kinases |
| Q90669751 | Assays for tyrosine phosphorylation in human cells |
| Q46299094 | Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy. |
| Q59808318 | Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia |
| Q41004137 | Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma. |
| Q89800303 | Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia |
| Q37701501 | Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo |
| Q39200710 | PI3K signaling in cancer: beyond AKT. |
| Q30008874 | Paralog-Specific Patterns of Structural Disorder and Phosphorylation in the Vertebrate SH3-SH2-Tyrosine Kinase Protein Family |
| Q101578696 | Recent advances in the discovery of multi-targeted tyrosine kinase inhibitors as anticancer agents |
| Q30234584 | Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews |
| Q61810285 | Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype |
| Q33620537 | Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond |
| Q98771243 | p28 Bacterial Peptide, as an Anticancer Agent |
Search more.